Impacted Tooth With Immediate Implant Placement (ImmediateIMP)
Surgical Extraction of an Impacted Canine and Immediate Implant Placement: A Prosthetically Guided Digital Approach
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bari, Italy, 70124
- Dr. Giuseppe D'Albis
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Refuse Orthodontic treatments
- Patients had to be healthy according to System of the American Society of Anesthesiology (ASA) and aged 18 years or older
- No general medical condition representing a contraindication to implant therapy
- minimum 2 missing teeth in the maxilla or mandible from the canine to the second molar
- No periodontal disease (periodontal probing depth <4 mm) or treated periodontitis
- Good oral hygiene (full mouth plaque index<25%)
- Adequate control of inflammation (full mouth bleeding on probing<25%)
Exclusion Criteria:
- smoking of more than 15 cigarettes a day
- untreated periodontal disease
- pregnancy or breastfeeding at date of inclusion
- acute infections
- keratinized mucosal tissue less than 2 mm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Patients with impacted tooth
Patient with impacted Maxillary Canine.
|
Following local anesthetic infiltration and a minimally invasive access, the atraumatic extraction of the impacted canine is performed, preserving the vestibular soft and bone tissues.
The implant site is then prepared, and the implant is placed using the surgical guide, with the required insertion torque to achieve primary implant stability.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Periimplant chart
Time Frame: 3 month after implant insertion, 1 year, 2 years
|
Probing the implant in 6 site.
|
3 month after implant insertion, 1 year, 2 years
|
|
ISQ
Time Frame: At implant insertion and after 3 months
|
Implant stability quotient.
( 0 - 100)
|
At implant insertion and after 3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Giuseppe D'Albis, Dr., University of Bari Aldo Moro
- Study Director: Saverio Capodiferro, Prof. Dr., University of Bari Aldo Moro
- Principal Investigator: Francesco Colacicco, University of Bari Aldo Moro
- Study Director: Massimo Corsalini, Prof. Dr., University of Bari Aldo Moro
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TiltedImplant2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.